BIOMAT Database Logo BIOMAT Database Logo

Alteration of mannose transport in fibroblasts from type I carbohydrate deficient glycoprotein syndrome patients. 1999

T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Laboratoire de Biochimie A, Hôpital Bichat, 75877, Paris Cedex 18, France.labo.bioa@bch.ap-hop-paris.fr

The aim of the present study was to explore how mannose enters fibroblasts derived from a panel of children suffering from different subtypes of type I carbohydrate deficient glycoprotein syndrome: seven carbohydrate deficient glycoprotein syndrome subtype Ia (phosphomannomutase deficiency), two carbohydrate deficient glycoprotein syndrome subtype Ib (phosphomannose isomerase deficiency) and two carbohydrate deficient glycoprotein syndrome subtype Ix (not identified deficiency). We showed that a specific mannose transport system exists in all the cells tested but has different characteristics with respect to carbohydrate deficient glycoprotein syndrome subtypes. Subtype Ia fibroblasts presented a mannose uptake equivalent or higher (maximum 1.6-fold) than control cells with a D-[2-3H]-mannose incorporation in nascent N-glycoproteins decreased up to 7-fold. Compared to control cells, the mannose uptake was greatly stimulated in subtype Ib (4.0-fold), due to lower Kuptake and higher Vmax values. Subtype Ib cells showed an increased incorporation of D-[2-3H]-mannose into nascent N-glycoproteins. Subtype Ix fibroblasts presented an intermediary status with mannose uptake equivalent to the control but with an increased incorporation of D-[2-3H]-mannose in nascent N-glycoproteins. All together, our results demonstrate quantitative and/or qualitative modifications in mannose transport of all carbohydrate deficient glycoprotein syndrome fibroblasts in comparison to control cells, with a relative homogeneity within a considered subtype of carbohydrate deficient glycoprotein syndrome. These results are consistent with the possible use of mannose as a therapeutic agent in carbohydrate deficient glycoprotein syndrome Ib and Ix.

UI MeSH Term Description Entries
D008358 Mannose A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. (From Grant & Hackh's Chemical Dictionary, 5th ed & Random House Unabridged Dictionary, 2d ed) D-Mannose,Mannopyranose,Mannopyranoside,D Mannose
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D018981 Congenital Disorders of Glycosylation A genetically heterogeneous group of heritable disorders resulting from defects in protein N-glycosylation. Carbohydrate-Deficient Glycoprotein Syndrome,Glycoprotein Syndrome, Carbohydrate-Deficient,Carbohydrate Deficient Glycoprotein Syndrome,Carbohydrate-Deficient Glycoprotein Syndromes,Syndrome, Carbohydrate-Deficient Glycoprotein,Syndromes, Carbohydrate-Deficient Glycoprotein

Related Publications

T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I.
October 1997, Acta paediatrica (Oslo, Norway : 1992),
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency.
July 1998, European journal of pediatrics,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.
March 1996, The Journal of clinical investigation,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Abnormal synthesis of mannose 1-phosphate derived carbohydrates in carbohydrate-deficient glycoprotein syndrome type I fibroblasts with phosphomannomutase deficiency.
February 1998, Glycobiology,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Carbohydrate deficient glycoprotein (CDG) syndrome type I.
January 1997, Journal of medical genetics,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Immunoglobulin levels in patients with carbohydrate-deficient glycoprotein syndrome type I.
October 1997, International archives of allergy and immunology,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I.
October 1996, Thrombosis and haemostasis,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Anesthesia considerations in carbohydrate-deficient glycoprotein syndrome type I.
October 2005, Paediatric anaesthesia,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose.
October 2001, Archives of disease in childhood,
T Dupre, and E Ogier-Denis, and S E Moore, and V Cormier-Daire, and M Dehoux, and G Durand, and N Seta, and P Codogno
Abnormal metabolism of mannose in families with carbohydrate-deficient glycoprotein syndrome type 1.
August 1997, Biochemical and molecular medicine,
Copied contents to your clipboard!